News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Laumas Sandeep
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 01/20/2023 |
4
| Laumas Sandeep (CFO and CBO) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 415,000 options to buy
@ $0.634, valued at
$263.1k
|
|
| 05/23/2022 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $13.24, valued at
$225.1k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 14,500 options to buy
@ $37.86, valued at
$549k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $49.74, valued at
$994.8k
|
|
| 05/04/2020 |
4
| Laumas Sandeep (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 424 convertible preferred
@ $0
Bought 424 options to buy
@ $0 |
|
| 05/04/2020 |
4
| Laumas Sandeep (Director) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 389,294 options to buy
@ $0.6, valued at
$233.6k
|
|
| 08/27/2019 |
4
| Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Granted 400,000 options to buy
@ $0.89, valued at
$356k
|
|
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 409 shares
@ $1.21, valued at
$494.9
Bought 591 shares
@ $1.22, valued at
$721 |
|
| 05/28/2019 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 14,700 options to buy
@ $10.04, valued at
$147.6k
|
|
| 05/23/2019 |
4
| Laumas Sandeep (CEO, Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 5,000 shares
@ $1.38, valued at
$6.9k
|
|
| 12/03/2018 |
4
| Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $2.64, valued at
$2.6k
Bought 1,000 shares
@ $2.62, valued at
$2.6k
Bought 1,000 shares
@ $2.63, valued at
$2.6k
|
|
| 11/29/2018 |
4
| Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 1,000 shares
@ $2.55, valued at
$2.6k
Bought 2,000 shares
@ $2.56, valued at
$5.1k
|
|
| 09/10/2018 |
4
| Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 500 shares
@ $6.1, valued at
$3.1k
|
|
| 08/30/2018 |
4
| Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 500 shares
@ $5.24, valued at
$2.6k
|
|
| 08/28/2018 |
4
| Laumas Sandeep (Executive Chairman) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought shares
@ $4.9, valued at
$0
Bought 250 shares
@ $4.88, valued at
$1.2k
Bought 95 shares
@ $5.07, valued at
$481.7
Bought 405 shares
@ $5.08, valued at
$2.1k
|
|
| 03/13/2018 |
4
| Laumas Sandeep (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 37,209 options
@ $11, valued at
$409.3k
|
|
|
|